Reaction

Insulin Resistance reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,023 reports · 45 co-occurring drugs

As of the last recalculation, Insulin Resistance appears in 2,023 FAERS reports alongside 45 co-occurring drug terms. The strongest observed disproportionality signal is INSULIN HUMAN (PRR 76.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Insulin Human	257	76.1	76.5
Insulin Lispro	501	49.3	49.4
Human Insulin	38	31.9	32.0
Insulin Aspart	182	31.0	31.1
Insulin Degludec	56	25.2	25.3
Insulin Glulisine	19	19.4	19.4
Olanzapine Pamoate	73	19.0	19.0
Insulin Glargine-Yfgn	39	18.7	18.7
Nevirapine	16	18.4	18.4
Insulin Glargine	336	16.6	16.6
Zidovudine	18	14.0	14.0
Abacavir Sulfate	10	10.6	10.6
Insulin	55	10.4	10.4
Olanzapine	97	9.7	9.7
Ziprasidone Mesylate	13	9.4	9.4
Brentuximab Vedotin	9	9.1	9.1
Liraglutide	40	8.5	8.5
Pioglitazone	35	8.5	8.5
Ziprasidone	14	8.2	8.2
Gemfibrozil	12	8.2	8.2
Dulaglutide	68	8.1	8.1
Metformin Er 500 Mg	203	7.6	7.6
Metformin Er 750 Mg	203	7.6	7.6
Metformin	228	7.3	7.3
Liothyronine Sodium	6	7.1	7.1
Alpelisib	6	7.1	7.1
Efavirenz	7	6.5	6.5
Lamivudine	18	6.0	6.0
Oral Semaglutide	42	6.0	6.0
Calcium, Magnesium, Potassium, And Sodium Oxybates	5	6.0	6.0
Empagliflozin	38	5.9	5.9
Lamivudine Oral	14	5.7	5.7
Aripiprazole	64	5.5	5.5
Naproxen Sodium Tablet, Coated	7	5.3	5.3
Naproxen Sodium, Coated Tablets	7	5.3	5.3
Naproxen Sodium 220Mg	7	5.3	5.3
Canagliflozin	13	4.5	4.5
Cariprazine	4	4.4	4.4
Somatropin	31	4.4	4.4
Methylphenidate	11	3.9	3.9
Lurasidone Hydrochloride	7	3.5	3.5
Exenatide	17	3.3	3.3
Rimegepant Sulfate	4	3.3	3.3
Orlistat	5	2.0	2.0
Tirzepatide	19	1.2	1.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.